IP Library Granted Patent US 8,313,819
Granted Patent B2
US 8,313,819 · App. 12/854,298 · Granted Nov 20, 2012

Ultra-thin multi-layer packaging

Assignee: Medos International S.A.R.L.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,313,819
App. No.
12/854,298
Granted
Nov 20, 2012
Kind
B2
Abstract

An implantable medical device including a plurality of components on a substrate, and a biocompatible multi-layer coating applied by vapor deposition to conform to and sealingly cover at least a portion of the components and/or the substrate. The coating is applied in at least two sets, each set having first, second and third layers. At least one of the first, second and third layers consist essentially of a polymer such as parylene and at least one of the other two layers of the set consist essentially of inorganic material such that each layer differs in at least one diffusion barrier property from the other layers in the set and adds to an overall barrier effect of the coating.

Claims (20)

1. An implantable medical device comprising:

a plurality of components on a substrate having at least a first three-dimensional portion; and

a biocompatible multi-layer coating applied by vapour deposition to conform to and sealingly cover at least the first portion of the components and the substrate, the coating having been applied in at least two sets, each set having at least first, second and third layers; and

at least one of the first, second and third layers consisting essentially of a polymer and at least one of the other two layers of the set consisting essentially of inorganic material such that each layer differs in at least one diffusion barrier property from the other layers in the set and adds to an overall barrier effect of the coating.

2. The implantable medical device of claim 1 wherein a barrier property for the transport of impurities is dominated more by the interface between adjacent layers than by the thickness of each individual layer.

3. The implantable medical device of claim 1 wherein diffusion through each layer differs from that of the other layers in the set.

4. The implantable medical device of claim 1 wherein the inorganic material is supplied by plasma enhanced chemical vapour deposition.

5. The implantable medical device of claim 1 wherein the inorganic material is generated from an in-situ plasma in a reactor.

6. The implantable medical device of claim 1 wherein the polymer is selected from di-p-xylylene and halogenated derivatives thereof supplied by chemical vapour deposition.

7. The implantable medical device of claim 6 wherein the polymer is supplied by chemical vapour deposition of dichloro-p-xylylene.

8. The implantable medical device of claim 1 wherein the inorganic materials are selected from the group consisting of metals, metal oxides, metal nitrides, metal carbides, metal oxynitrides, metal oxyborides semi-metals, semi-metal oxides, semi-metal nitrides, semi-metal carbides, semi-metal oxynitrides, and combinations thereof.

9. The implantable medical device of claim 1 wherein the components have at least a first three-dimensional portion, and the coating conforms to and sealingly covers at least the first portion of the components.

10. The implantable medical device of claim 9 wherein the multi-layer coating conforms to and sealingly covers at least substantially all of the components.

11. An implantable medical device comprising:

a plurality of components on a substrate having at least a first three-dimensional portion; and

a biocompatible multi-layer coating applied by vapour deposition to conform to and sealingly cover at least the first portion of the components and the substrate, the coating having been applied in at least two sets, each set having essentially first, second and third layers;

at least one of the first, second and third layers consisting essentially of a parylene and at least one of the other two layers of the set consisting essentially of inorganic material; and

wherein a diffusion barrier property through each layer differs from that of the other layers in the set and adds to an overall barrier effect of the coating.

12. The implantable medical device of claim 9 wherein the multi-layer coating conforms to and sealingly covers at least substantially all of the components and the substrate.

13. The implantable medical device of claim 10 wherein a barrier property for the transport of impurities is dominated more by the interface between adjacent layers than by the thickness of each individual layer.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2019
From: INTEGRA LIFESCIENCES SWITZERLAND SÀRL
To: COAT-X SA
Reel/Frame 049481/0776 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2018
From: MEDOS INTERNATIONAL SARL
To: INTEGRA LIFESCIENCES SWITZERLAND SARL
Reel/Frame 044741/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2010
From: HOGG, ANDREAS; KEPPNER, HERBERT; AELLEN, THEIRRY; BURGER, JUERGEN
To: MEDOS INTERNATIONAL S.A.R.L.
Reel/Frame 024942/0480 →
Continuity (2)
Provisional Application 61233395 · Aug 12, 2009
Related Publication 20110039050A1 · Feb 17, 2011